Multitarget Inhibition of Drug-Resistant Multiple Myeloma Cell Lines by Dimethyl-Celecoxib (DMC), a Non-Cox-2 Inhibitory Analog of Celecoxib

Blood - United States
doi 10.1182/blood-2005-07-2819